Evidence map›Paper›PMID 33505158›Full record

ArticleDrug design, development and therapy2021

Gracillin Isolated from

Jianqiong Yang, Ling Cao, Yamei Li, Hai Liu, Minhong Zhang, Huamou Ma, Biao Wang, Xiaoliang Yuan, Qian Liu

Abstract read
In one paragraph

Article in Drug design, development and therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. The role ofHeliyon · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Common methods in mitochondrial research (Review).International journal of molecular medicine · 2022
    Article
  13. Article
  14. Dichloromethane fractions ofMolecular medicine reports · 2022
    Article
  15. Study of Saponin Components after Biotransformation ofJournal of analytical methods in chemistry · 2022
    Article
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jianqiong Yang *Department of Clinical Medicine Research Center, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.ORCID 0000-0002-9063-8117
Ling Cao *College of Pharmacy, Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
Yamei Li *College of Pharmacy, Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
Hai Liu *College of Pharmacy, Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.ORCID 0000-0002-1748-0990
Minhong ZhangDepartment of Clinical Medicine Research Center, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
Huamou MaDepartment of Clinical Medicine Research Center, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
Biao WangDepartment of Clinical Medicine Research Center, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
Xiaoliang YuanDepartment of Respiratory Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.
Qian LiuKey Laboratory of Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases of Ministry of Education, Gannan Medical University, Ganzhou, Jiangxi, People's Republic of China.ORCID 0000-0003-1642-4329

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPURPOSE: Clarify the antiproliferation effect of gracillin on A549 cells and further explore its mechanisms via the mitochondrial pathway.

methodsGracillin was isolated and purified by silica gel, D-101 macroporous resin and preparative RP-HPLC, then identified by NMR and HR-MS. The inhibitory effects of gracillin on the proliferation of A549 cells were detected by the MTS method. Its mechanisms were further explored by flow cytometry and Western blot.

resultsA steroid saponin, gracillin, was isolated and identified from

conclusionThis study confirmed that gracillin has a significant antiproliferative effect on A549 cells. Gracillin could induce the apoptosis of A549 cells through the mitochondrial pathway, which might be associated with regulation of the concentration of intracellular calcium, the mitochondrial membrane potential and the expression levels of Bax, Bcl-2, caspase-3, cleaved caspase-3, and cytochrome C.

Indexed as

Antineoplastic Agents, PhytogenicApoptosisCell ProliferationCells, CulturedDrugs, Chinese HerbalDrug Screening Assays, AntitumorHumansLiliaceaeMitochondriaSpirostansAntineoplastic Agents, PhytogenicDrugs, Chinese HerbalgracillinSpirostansA549 cellsantiproliferative activityapoptosisgracillinReineckia carnea

Identifiers

PMID33505158
PMCPMC7829125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.